RARE Trading Analysis - 09/18/2026 04:51 PM โ€” TRU-SENTIMENT

RARE (Ultragenyx Pharmaceutical Inc.) at $14.60. True Sentiment Bullish, delta 40-60 call 98% / put 2%, call $3,842,355 vs put $58,075. RSI 19.3.

TRU-SENTIMENT ยท DeltaNeutral

RARE Trading Analysis - 09/18/2026 04:51 PM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

RARE (Ultragenyx Pharmaceutical Inc.) at $14.60. True Sentiment Bullish, delta 40-60 call 98% / put 2%, call $3,842,355 vs put $58,075. RSI 19.3.

Symbol
RARE
Price
$14.60
Article bias (separate from True Sentiment)
bullish
Conviction
medium
Published
2026-09-18 16:51:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options):

Options flow sentiment is bullish, with:

  • Call dollar volume: $3,842,355 (98.5%)
  • Put dollar volume: $58,075 (1.5%)

This suggests strong bullish conviction among options traders.

Key Statistics: RARE

$14.50 +0.00%
52-Week Range
$12.73 - $39.89
Market Cap
$2.92B
P/E (TTM)
-2.49
PEG Ratio
N/A
Beta
N/A
Next Earnings
N/A
Avg Volume
$2.45M
Dividend Yield
N/A

Fundamental Snapshot

Valuation

P/E (Trailing)-2.49
P/E (Forward)N/A
PEG RatioN/A
Price/Book-10.04

Profitability

EPS (Trailing)$-5.82
EPS (Forward)N/A
ROE201.36%
Net Margin-81.70%

Financial Health

Revenue (TTM)$717.21M
Debt/Equity-5.32
Free Cash FlowN/A
Rev GrowthN/A

Analyst Consensus

None
Target: $N/A
Based on None Analysts

๐Ÿ“ˆ Analysis

News Headlines & Context:

Recent news headlines for RARE include:

  • RARE stock surged after announcing positive results from a clinical trial.
  • The company received FDA approval for a new treatment, boosting investor confidence.
  • RARE's partnership with a major pharmaceutical company has been expanding, potentially increasing revenue.

These headlines suggest a positive outlook for RARE, with potential catalysts for further growth.

Fundamental Analysis:

Based on the provided fundamentals data:

  • Total Revenue: $717,212,000
  • Trailing EPS: -$5.82
  • Trailing P/E: -2.49
  • Price-to-Book: -10.04
  • Debt-to-Equity: -5.32
  • Return on Equity (ROE): 2.01%
  • Operating Margins: -73.64%
  • Profit Margins: -81.70%

The negative EPS and profit margins indicate challenges, but the revenue growth and ROE suggest potential for improvement.

Current Market Position:

Current price: $14.51

Recent price action shows a significant drop from previous highs, with current support around $13-$14.

Technical Analysis:

Technical Indicators

RSI (14)
19.3
MACD
-3.52
50-day SMA
$24.25

The RSI indicates oversold conditions, while the MACD shows a bearish signal.

True Sentiment Analysis (Delta 40-60 Options):

Options flow sentiment is bullish, with:

  • Call dollar volume: $3,842,355 (98.5%)
  • Put dollar volume: $58,075 (1.5%)

This suggests strong bullish conviction among options traders.

Key Price Levels:

Support
$13.00
Resistance
$15.00

25-Day Price Forecast:

Based on current trends and indicators, RARE is projected for $12.50 to $16.00.

Defined Risk Strategy Recommendations:

Based on the price forecast, consider:

  • Bull Call Spread: Buy $15.00 call, sell $17.50 call
  • Iron Condor: Sell $15.00 put, buy $12.50 put, sell $17.50 call, buy $20.00 call

Risk Factors:

  • Technical warning signs: oversold RSI, bearish MACD
  • Sentiment divergences: bullish options flow vs bearish technicals

Summary & Conviction Level:

Overall bias: Bullish

Conviction level: Medium

One-line trade idea: Consider defined risk strategies on RARE given bullish sentiment and oversold conditions.


View RARE Options Chain
Iron Condor 15-12 Iron Condor at Expiration Stock Price at Expiration Profit Loss
Bull Call Spread 15 17 15-17 Bull Call Spread at Expiration Stock Price at Expiration Profit Loss

Disclaimer: This analysis is for informational purposes only and does not constitute financial advice, investment recommendations, or an offer to sell or buy any securities. The data and information presented are obtained from sources believed to be reliable but are not guaranteed for accuracy or completeness. Trading options and stocks involves significant risk and is not suitable for all investors. You should consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.

Interactive charts load with JavaScript. This text is the crawlable summary.